Catalyst Wire Dossier Catalyst Wire Dossier
EMA guidance · 2009-05-08

European Medicines Agency gives guidance for use of antiviral medicines in case of a novel influenza A/H1N1 pandemic

View source ↗

Summary

The EMA provides guidance on how antiviral medicines should be used in the event of a novel influenza A/H1N1 pandemic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications